These results suggest that PDK4 is involved in the development and drug resistance in CRC, though high hepatic, but not tumoural expression of PDK4 is associated with improved survival in patients undergoing surgical operation of resectable colorectal liver metastases23. Here, PDK4 is linked to medical procedure.